These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1352395)

  • 21. Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a.
    Heizmann O; Haecker FM; Zumsteg U; Müller B; Oberholzer M; Oertli D
    Eur J Surg Oncol; 2006 Feb; 32(1):98-102. PubMed ID: 16325365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mineral metabolic effects of thyroidectomy and long-term outcomes in a family with MEN 2A.
    Bone HG; Deftos LJ; Snyder WH; Pak CY
    Henry Ford Hosp Med J; 1992; 40(3-4):258-60. PubMed ID: 1362418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic variables and calcitonin in medullary thyroid cancer.
    Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
    Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Problems posed by the detection of familial medullary cancer of the thyroid in children].
    Delépine N; Desbois JC
    Biomed Pharmacother; 1984; 38(9-10):434-9. PubMed ID: 6152183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical value of tumor doubling estimations in multiple endocrine neoplasia type II.
    Jackson CE; Talpos GB; Block MA; Norum RA; Lloyd RV; Tashjian AH
    Surgery; 1984 Dec; 96(6):981-7. PubMed ID: 6150555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [MEN 2A syndrome: report of a family].
    Krassowski J; Gabryelewicz MB; Jeske W; Zgliczyński S
    Pol Merkur Lekarski; 2000 Jul; 8(49):481-2. PubMed ID: 11070721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin.
    Mirallié E; Iacobone M; Sebag F; Henry JF
    Eur J Surg Oncol; 2004 Sep; 30(7):790-5. PubMed ID: 15296996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical treatment of medullary thyroid carcinoma in a thirteen-year-old girl with MEN 2B.
    Tisell LE; Jansson S
    Henry Ford Hosp Med J; 1989; 37(3-4):157-9. PubMed ID: 2576953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcitonin gene-related peptide and calcitonin as tumour markers in MEN 2 family screening.
    Schifter S
    Clin Endocrinol (Oxf); 1989 Mar; 30(3):263-70. PubMed ID: 2574082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcitonin immunoreactivity and hypercalcitoninemia in two patients with sporadic, nonfamilial, gastroenteropancreatic neuroendocrine tumors.
    McLeod MK; Vinik AI
    Surgery; 1992 May; 111(5):484-8. PubMed ID: 1350867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medullary thyroid carcinoma and calcitonin.
    Emmertsen K
    Dan Med Bull; 1985 Mar; 32(1):1-28. PubMed ID: 2859145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience with a provocative test of calcitonin release as a prospective screening for preclinical medullary thyroid carcinoma in MEN type 2A family members.
    van Lathem JJ; Vermaak WJ; Kuyl JM; Mollentze W; Jansen S; Wolmarans L; Pelser H; Barry R; Kruger AJ; Wolfaardt M
    J Clin Lab Anal; 1992; 6(6):384-90. PubMed ID: 1359042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medullary carcinoma of the thyroid gland.
    Shapiro MJ
    Am Surg; 1977 Sep; 43(9):601-9. PubMed ID: 20013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early diagnosis of the multiple endocrine neoplasia type 2 syndrome: consensus statement. European Community Concerted Action: Medullary Thyroid Carcinoma.
    Calmettes C; Ponder BA; Fischer JA; Raue F
    Eur J Clin Invest; 1992 Nov; 22(11):755-60. PubMed ID: 1362156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of papillary thyroid carcinoma in multiple endocrine neoplasia type 2A.
    Decker RA
    Surgery; 1993 Dec; 114(6):1059-63. PubMed ID: 7903002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medullary Thyroid Carcinoma: Prognostic Variables And Tumour Markers Affecting Survival.
    Hassan A; Siddique M; Riaz S; Khan AI; Nawaz MK; Bashir H
    J Ayub Med Coll Abbottabad; 2018; 30(Suppl 1)(4):S627-S632. PubMed ID: 30838820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple endocrine neoplasia type II: the role of gastrointestinal humoral factors in calcitonin release following alcohol and pentagastrin stimulation.
    Fletcher DR; Gamvros O; Man WK; Ahmed Y; Trayner I; Adrian T
    Aust N Z J Surg; 1984 Jun; 54(3):271-5. PubMed ID: 6147130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcitonin and PDN-21 as tumour markers in MEN-2 family screening for medullary thyroid carcinoma.
    Schifter S
    Eur J Cancer; 1992; 28(2-3):341-5. PubMed ID: 1350454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of calcium pentagastrin and TRH tests in screening for medullary carcinoma of the thyroid in MEN IIA.
    O'Connell JE; Dominiczak AF; Isles CG; McLellan AR; Davidson G; Gray CE; Connell JM
    Clin Endocrinol (Oxf); 1990 Apr; 32(4):417-21. PubMed ID: 1971777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.